UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Percutaneous treatment of extrahepatic recurrence of hepatocellular carcinoma

Diagnostic and interventional imaging, 2016-11, Vol.97 (11), p.1117-1123

2016

Volltextzugriff (PDF)

Sulfatase 2 Along with Syndecan 1 and Glypican 3 Serum Levels are Associated with a Prognostic Value in Patients with Alcoholic Cirrhosis-Related Advanced Hepatocellular Carcinoma

Journal of hepatocellular carcinoma, 2022, Vol.9, p.1369-1383

2022

Volltextzugriff (PDF)

Changes in the serum proteome associated with the development of hepatocellular carcinoma in hepatitis C-related cirrhosis

British journal of cancer, 2006-01, Vol.94 (2), p.287-292

2006

Volltextzugriff (PDF)

1024 IDENTIFICATION OF SERUM PROTEOGLYCANS AS PROGNOSTIC BIOMARKERS IN PATIENTS WITH HEPATOCELLULAR CARCINOMA AND ALCOHOLIC CIRRHOSIS

Journal of hepatology, 2012-04, Vol.56, p.S400-S401

2012

Volltextzugriff (PDF)

Preclinical and post-treatment changes in the HCC-associated serum proteome

British journal of cancer, 2006-11, Vol.95 (10), p.1379-1383

2006

Volltextzugriff (PDF)

1030 EPCAM EXPRESSION BY TUMOR CELLS IS AN INDEPENDENT PREDICTIVE FACTOR FOR DISTANT RECURRENCE IN UNINODULAR HEPATOCELLULAR CARCINOMA (≤5CM) TREATED BY RADIOFREQUENCY ABLATION

Journal of hepatology, 2011-03, Vol.54, p.S409-S409

2011

Volltextzugriff (PDF)

215 A PHASE II OPEN LABEL TRIAL EVALUATING SAFETY AND EFFICACY OF A TELOMERASE PEPTIDE VACCINATION IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA

Journal of hepatology, 2010, Vol.52, p.S92-S92

2010

Volltextzugriff (PDF)

21 FUNCTIONAL RELEVANT TELOMERASE MUTATIONS ASSOCIATE WITH CIRRHOSIS FORMATION IN PATIENTS WITH CHRONIC LIVER DISEASE

Journal of hepatology, 2010, Vol.52, p.S9-S10

2010

Volltextzugriff (PDF)

Results of percutaneous radiofrequency ablation of hepatocellular carcinoma in patients with cirrhosis aged 75 years and over

La revue de medecine interne, 2012-03, Vol.33 (3), p.128-133

2012

Volltextzugriff (PDF)

64 EXPRESSION OF BILIARY CELL CYTOKERATIN BY HEPATOCYTES IN NON TUMORAL LIVER BIOPSY IS RELATED TO SUBSEQUENT HEPATOCELLULAR CARCINOMA OCCURRENCE IN HCV RELATED CIRRHOSIS

Journal of hepatology, 2009, Vol.50, p.S27-S28

2009

Volltextzugriff (PDF)

HCV genotype 3 is associated with a higher hepatocellular carcinoma incidence in patients with ongoing viral C cirrhosis

Journal of viral hepatitis, 2011-10, Vol.18 (10), p.e516-e522

2011

Volltextzugriff (PDF)

Résultats du traitement par radiofréquence du carcinome hépatocellulaire chez le cirrhotique âgé de 75 ans et plus

La revue de medecine interne, 2012-03, Vol.33 (3), p.128-133

2012

Volltextzugriff (PDF)

Genetic dimorphism in superoxide dismutase and susceptibility to alcoholic cirrhosis, hepatocellular carcinoma, and death

Clinical gastroenterology and hepatology, 2005-03, Vol.3 (3), p.292-298

2005

Volltextzugriff (PDF)

Determinants of long term survival and recurrence patterns after radiofrequency ablation for hepatocellular carcinoma developed on cirrhosis

Journal of hepatology, 2017, Vol.66 (1), p.S446-S446

2017

Volltextzugriff (PDF)

Local/Regional and Systemic Treatments of Hepatocellular Carcinoma

Seminars in liver disease, 2005, Vol.25 (2), p.201-211

2005

Volltextzugriff (PDF)

Partial splenic embolization in patients with cirrhosis: efficacy, tolerance and long-term outcome in 32 patients

European journal of gastroenterology & hepatology, 2005-02, Vol.17 (2), p.179-184

2005

Volltextzugriff (PDF)

Radiofrequency Ablation for the Treatment of Liver Tumors in the Caudate Lobe

Journal of vascular and interventional radiology, 2005-07, Vol.16 (7), p.981-990

2005

Volltextzugriff (PDF)

Telomerasemutationen sind mit der Entstehung von Leberzirrhose assoziiert

Zeitschrift für Gastroenterologie, 2010, Vol.48 (8)

2010

Volltextzugriff (PDF)

Randomized trial of leuprorelin and flutamide in male patients with hepatocellular carcinoma treated with tamoxifen

Hepatology (Baltimore, Md.), 2004-12, Vol.40 (6), p.1361-1369

Trinchet, Jean–Claude

2004

Volltextzugriff (PDF)

653 MULTIPOLAR RADIOFREQUENCY ABLATION FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA >5CM IN DIAMETER: TOLERANCE AND RESULTS AT 3 YEARS

Journal of hepatology, 2011-03, Vol.54, p.S264-S264

2011

Volltextzugriff (PDF)

652 MULTIPOLAR RADIOFREQUENCY ABLATION (MRFA) FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA (HCC) IN PATIENTS WITH CIRRHOSIS: PRELIMINARY EXPERIENCE IN 109 PATIENTS

Journal of hepatology, 2011-03, Vol.54, p.S263-S263

2011

Volltextzugriff (PDF)

Large infiltrative hepatocellular carcinomas: treatment with percutaneous intraarterial ethanol injection alone or in combination with conventional percutaneous ethanol injection

Radiology, 2005-01, Vol.234 (1), p.299-309

2005

Volltextzugriff (PDF)

398 PREDICTIVE FACTORS OF HCC FREE SURVIVAL IN 203 PATIENTS WITH CIRRHOSIS CLASSED CHILD PUGH A AND HCC (≤ 5CM) TREATED BY RADIOFREQUENCY ABLATION (RFA)

Journal of hepatology, 2008, Vol.48, p.S154-S154

2008

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(48)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Percutaneous treatment of extrahepatic recurrence of hepatocellular carcinoma

Sulfatase 2 Along with Syndecan 1 and Glypican 3 Serum Levels are Associated with a Prognostic Value in Patients with Alcoholic Cirrhosis-Related Advanced Hepatocellular Carcinoma

Changes in the serum proteome associated with the development of hepatocellular carcinoma in hepatitis C-related cirrhosis

1024 IDENTIFICATION OF SERUM PROTEOGLYCANS AS PROGNOSTIC BIOMARKERS IN PATIENTS WITH HEPATOCELLULAR CARCINOMA AND ALCOHOLIC CIRRHOSIS

Preclinical and post-treatment changes in the HCC-associated serum proteome

1030 EPCAM EXPRESSION BY TUMOR CELLS IS AN INDEPENDENT PREDICTIVE FACTOR FOR DISTANT RECURRENCE IN UNINODULAR HEPATOCELLULAR CARCINOMA (≤5CM) TREATED BY RADIOFREQUENCY ABLATION

215 A PHASE II OPEN LABEL TRIAL EVALUATING SAFETY AND EFFICACY OF A TELOMERASE PEPTIDE VACCINATION IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA

21 FUNCTIONAL RELEVANT TELOMERASE MUTATIONS ASSOCIATE WITH CIRRHOSIS FORMATION IN PATIENTS WITH CHRONIC LIVER DISEASE

Results of percutaneous radiofrequency ablation of hepatocellular carcinoma in patients with cirrhosis aged 75 years and over

64 EXPRESSION OF BILIARY CELL CYTOKERATIN BY HEPATOCYTES IN NON TUMORAL LIVER BIOPSY IS RELATED TO SUBSEQUENT HEPATOCELLULAR CARCINOMA OCCURRENCE IN HCV RELATED CIRRHOSIS

HCV genotype 3 is associated with a higher hepatocellular carcinoma incidence in patients with ongoing viral C cirrhosis

Résultats du traitement par radiofréquence du carcinome hépatocellulaire chez le cirrhotique âgé de 75 ans et plus

Genetic dimorphism in superoxide dismutase and susceptibility to alcoholic cirrhosis, hepatocellular carcinoma, and death

Determinants of long term survival and recurrence patterns after radiofrequency ablation for hepatocellular carcinoma developed on cirrhosis

Local/Regional and Systemic Treatments of Hepatocellular Carcinoma

Partial splenic embolization in patients with cirrhosis: efficacy, tolerance and long-term outcome in 32 patients

A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis

A 2-year multicenter, double-blind, randomized, placebo-controlled study of bezafibrate for the treatment of primary biliary cholangitis in patients with inadequate biochemical response to ursodeoxycholic acid therapy (Bezurso)

Radiofrequency Ablation for the Treatment of Liver Tumors in the Caudate Lobe

Telomerasemutationen sind mit der Entstehung von Leberzirrhose assoziiert

Randomized trial of leuprorelin and flutamide in male patients with hepatocellular carcinoma treated with tamoxifen

653 MULTIPOLAR RADIOFREQUENCY ABLATION FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA >5CM IN DIAMETER: TOLERANCE AND RESULTS AT 3 YEARS

652 MULTIPOLAR RADIOFREQUENCY ABLATION (MRFA) FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA (HCC) IN PATIENTS WITH CIRRHOSIS: PRELIMINARY EXPERIENCE IN 109 PATIENTS

Large infiltrative hepatocellular carcinomas: treatment with percutaneous intraarterial ethanol injection alone or in combination with conventional percutaneous ethanol injection

398 PREDICTIVE FACTORS OF HCC FREE SURVIVAL IN 203 PATIENTS WITH CIRRHOSIS CLASSED CHILD PUGH A AND HCC (≤ 5CM) TREATED BY RADIOFREQUENCY ABLATION (RFA)

Suchergebnisse filtern